Achim Kless

Senior Director

Eli Lilly

Amalia Papanikolaou

Data Programme Lead

Challenge Works, Nesta

Amanda Guise

s

Biogen

Amy Easton

Senior Director of Scientific Programs

Target ALS

Andrew Lo

Professor

Massachusetts Institute of Technology

Anil Tarachandani

Vice President & Head of Translational Medicine

Verge Genomics

Arti Patel

Principal Scientist, Neuroscience Program Lead

Novartis AG

Asa Abeliovich

Chief Executive Officer & Founder

Leal Therapeutics

Bob Dagher

Executive Vice President & Chief Medical Officer

Brainstorm Cell Therapeutics

Chee Chung

Vice President & Head of CNS Therapies

Arbor Biotechnologies

Christopher Bunker

Chief Business Officer

Alamar Biosciences

Daniel Fowler

Chief Medical & Scientific Officer

Rapa Therapeutics

Deborah Bellina

ALS Advoacate & Caregiver

Emma Bowden

Senior Vice President & Head of Development

QurAlis

Erin Fleming

Chief Operating Officer

ProJenX

Ethan Ash

Executive Vice President - Business Development

Bionews

Fernando Vieira

Chief Executive Officer and Chief Science Officer

ALS Therapy Development Institute

Hariprasad Vankayalapati

Chief Scientific Officer

Biolexis Therapeutics

Ignazio Di Giovanna

VP, Scientific Affairs, Neurology

Atlantic Research Group

Isaac Klein

Chief Scientific Officer

Dewpoint Therapeutics

James Berry

Associate Neurologist

Massachusetts General Hospital

John Nieland

Co-Founder & Chief Scientific Officer

2N Pharma

Kai-Bin Ooi

Director, Drug Development Operations

Athira Pharma

Leticia Tarilonte

Head of Clinical Operations

BrainStorm Cell Therapeutics

Makoto Tamura

Senior Director, NeuroDiscovery Lab

Mitsubishi Tanabe Pharma America

Marcel Van Der Brug

Chief Scientific Officer

AcuraStem

Marcella Debidda

President Patient Insights & Clinical Solutions

Bionews

Mark Roskey

Chief Scientific & Collaboration Officer

Quanterix

Martin Jacko

Chief Executive Officer

Aperture Therapeutics

Mary Kay Turner

Senior Vice President - Global Advocacy & Public Affairs

BrainStorm Cell Therapeutics

Matt Mandeville

Applications | BD

BrainXell

Michael Thurn

Chief Executive Officer

Neurizon

Netta Blondheim-Shraga

Senior Vice President, Research & Development

Brainstorm Cell Therapeutics

Olga Uspenskaya-Cadoz

Chief Medical Officer

VectorY Therapeutics

Philip C. Wong

Professor of Pathology

Johns Hopkins Medicine

Ray Kelleher

Managing Director

Cormorant Asset Management

Richard Fisher

Chief Scientific Officer

Eikonizo Therapeutics

Richard Ransohoff

Venture Partner

Third Rock Venturers

Ron Hoffman

Founder & Executive Director

Compassionate Care Group

Sabrina Paganoni

Co-Director, Neurological Clinical Research Institute

Massachusetts General Hospital

Sherif Reda

Director

Athira Pharma

Terry Fang

Senior Director - Preclinical Science

Trace Neuroscience

Tetsuya Tanaka

Vice President, Stem Cell Biology

Elixirgen Scientific

Timothy Piser

Head of Research & Development

Samsara Therapeutics

Tiziana Petrozziello, Ph.D.

Instructor of Neurology

Harvard Medical School

Wendy Hendrickson

Person Living with ALS

ALS Hope Foundation

Wolfgang Liedtke

Head of Neurology, Professor of Neurology

Anavex Life Sciences & Duke University